AYTU BIOPHARMA, INC Annual Cost of Revenue in USD from 2015 to 2022

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Aytu Biopharma, Inc quarterly/annual Cost of Revenue history and growth rate from 2015 to 2022.
  • Aytu Biopharma, Inc Cost of Revenue for the quarter ending March 31, 2023 was $9.99M, a 13.2% decline year-over-year.
  • Aytu Biopharma, Inc Cost of Revenue for the twelve months ending March 31, 2023 was $41.2M, a 6.27% decline year-over-year.
  • Aytu Biopharma, Inc annual Cost of Revenue for 2022 was $44.4M, a 21.8% increase from 2021.
  • Aytu Biopharma, Inc annual Cost of Revenue for 2021 was $36.4M, a 340% increase from 2020.
  • Aytu Biopharma, Inc annual Cost of Revenue for 2020 was $8.28M, a 276% increase from 2019.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Annual (USD)
Cost of Revenue, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $44.4M +$7.95M +21.8% Jul 1, 2021 Jun 30, 2022 10-K 2022-09-27
2021 $36.4M +$28.2M +340% Jul 1, 2020 Jun 30, 2021 10-K 2022-09-27
2020 $8.28M +$6.08M +276% Jul 1, 2019 Jun 30, 2020 10-K 2021-09-28
2019 $2.2M +$151K +7.39% Jul 1, 2018 Jun 30, 2019 10-K 2020-10-06
2018 $2.05M +$633K +44.7% Jul 1, 2017 Jun 30, 2018 10-K 2019-09-26
2017 $1.42M +$460K +48.1% Jul 1, 2016 Jun 30, 2017 10-K 2018-09-06
2016 $957K +$869K +986% Jul 1, 2015 Jun 30, 2016 10-K 2017-08-31
2015 $88.1K Jul 1, 2014 Jun 30, 2015 10-K 2016-09-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.